Cintrifuse

Cintrifuse is a Cincinnati-based organization dedicated to fostering high-growth startups by connecting entrepreneurs with strategic businesses, research institutions, mentors, and investors. It plays a pivotal role in coordinating the activities and resources of the region's innovation ecosystem, linking incubators, accelerators, and various investment sources to enhance collaboration and information sharing. Cintrifuse focuses on three essential elements to cultivate a sustainable innovation economy: Access, Place, and Fund. By leveraging these core components, the organization aims to support the successful launch and growth of startups in the area, while also promoting the overall development of the local entrepreneurial landscape.

Santiago Garcia

Principal

Alisa Smith

Director of Venture Services

6 past transactions

Nichefire

Seed Round in 2025
Nichefire is an artificial intelligence-driven marketing analytics company that specializes in consumer insights. The company has developed a platform that simplifies business decision-making by activating and interpreting online brand and consumer interactions. Utilizing advanced AI technology, Nichefire's platform efficiently collects, sorts, and categorizes vast amounts of data from posts, comments, and reactions in mere seconds. This capability enables businesses to derive smarter insights and anticipate cultural trends that may influence their products, services, and overall strategies. By providing actionable analytics, Nichefire empowers organizations to make informed decisions and stay competitive in a rapidly evolving market.

Cloverleaf.me

Series A in 2024
Cloverleaf LLC offers a visualization and scenario-planning platform designed to enhance team management and employee development. Founded in 2015 and based in Covington, Kentucky, the platform analyzes employee data to provide insights into team dynamics by cross-mapping personality traits, skills, and organizational culture. This enables users, including agile practitioners, project managers, and human resource professionals, to position team members effectively, improve communication, and identify suitable candidates to boost productivity. Additionally, Cloverleaf's automated coaching features deliver personalized nudges through commonly used tools like Google Workspace, Microsoft Outlook, and Slack, fostering collaboration and performance improvements within teams.

Enable Injections

Series C in 2022
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.

Struxtion

Seed Round in 2021
Struxtion offers an online financing platform tailored for underserved commercial construction contractors. The platform aims to maintain the financial health of these contractors by providing cost-effective working capital solutions. It collects and analyzes project-related information to deliver optimal pricing, ultimately empowering contractors with the necessary financial support to thrive in their projects.

Enable Injections

Series B in 2018
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.

Enable Injections

Series A in 2016
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.